Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2023

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Special Shareholder Meeting, Announces Key New Hires

Posted on January 26, 2023 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is releasing results from its reconvened Special Meeting of Stockholders. The meeting, which was held on Jan. 25, 2023, included several proxy proposals on the agenda; MULN is reporting that … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Year-End Webcast Review

Posted on January 26, 2023 by MissionIR

Flora Growth (NASDAQ: FLGC), a leading outdoor grower, manufacturer and distributor of cannabis products and brands worldwide, has scheduled a webcast to provide an overview of the company’s operational milestones achieved in 2022. The year-end review is slated for Jan. … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

Silo Pharma Inc. (NASDAQ: SILO) Provides Update on UCSF Psylocibin Clinical Trial

Posted on January 26, 2023 by MissionIR

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company that fuses traditional medicine with psychedelics, recently provided a progress update on its sponsored clinical trial with the University of California, San Francisco (“UCSF”) examining the effect of psilocybin on inflammation. … Continue reading →

Posted in Silo Pharma Inc. SILO | Leave a comment

MissionIRNewsBreaks – CISO Global Inc. (NASDAQ: CISO) CEO Discusses Top-down Culture of Cybersecurity in ‘Shrimp Tank’ Interview

Posted on January 25, 2023 by MissionIR

CISO Global (NASDAQ: CISO), an industry leader in managed cybersecurity and compliance services, was featured on a recent episode of “The Shrimp Tank.” The company’s CEO David Jemmett joined podcast host Ted Jenkin to discuss CISO Global’s approach to cybersecurity, … Continue reading →

Posted in Cerberus Cyber Sentinel Corp. CISO | Leave a comment

MissionIRNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) $4.1M Placements Supported by Aegis Capital Corp. as Exclusive Placement Agent

Posted on January 25, 2023 by MissionIR

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, recently announced the closing of both a registered direct and a private placement; the placements totaled approximately $4.1 million. Aegis Capital Corp. acted as exclusive placement agent … Continue reading →

Posted in Jupiter Wellness Inc. JUPW | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability to Meet Underserved Medical Needs

Posted on January 25, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is using its patented DehydraTECH(TM) technology to improve bioavailability and how active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery, helping with the speed of … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Set to Potentially Benefit as Renowned Gold Bug, Claude Bejet, Says Now is the Time to Invest in Precious Metals

Posted on January 25, 2023 by MissionIR

 “We’ve been through hell.” That was Claude Bejet’s succinct summary of the precious metals market and gold over the past two years. A Covid-linked downturn in 2020 was subsequently followed by an inflation-driven bear market across financial assets in 2022; … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses ‘Lifeblood’ of Phase 2 Berubicin Trial

Posted on January 24, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company focused on developing novel treatments for primary and metastatic cancers in the brain and central nervous system, is enrolling patients in a phase 2 trial to evaluate the efficacy of its flagship … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Working Toward Global Leadership in CBD Space

Posted on January 24, 2023 by MissionIR

Flora (NASDAQ: FLGC) has transitioned from the development stage to a full-scale international distributor with operations in over 12 countries worldwide, achieved under Luis Merchan’s tenure as CEO. “Merchan has also spearheaded several mergers and acquisitions, most notably JustCBD and … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

MissionIRNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Senior Medical Tech Veteran as New President

Posted on January 24, 2023 by MissionIR

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, has appointed Robert Eno to the newly created position of president. A senior medical technology executive, … Continue reading →

Posted in HeartBeam Inc. BEAT | Leave a comment